Selected research
Industry Research
Bioartificial Organ Manufacturing Industry Research Report 2026
Market perspective
The global Bioartificial Organ Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioartificial Organ Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioartificial Organ Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioartificial Organ Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioartificial Organ Manufacturing include B. Braun, Boston Scientific Corporation, ABIOMED, Asahi Kasei Corporation, Berlin Heart, CARMAT, Jarvik Heart, SynCardia Systems and Nipro Europe Group Companies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioartificial Organ Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioartificial Organ Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioartificial Organ Manufacturing Market by Company
B. Braun
Boston Scientific Corporation
ABIOMED
Asahi Kasei Corporation
Berlin Heart
CARMAT
Jarvik Heart
SynCardia Systems
Nipro Europe Group Companies
Organovo Holdings
NexImmune
Diabeloop
Admetsys
Defymed
Pancreum
Beta Bionics
Integra LifeSciences
Wake Forest Institute for Regenerative Medicine (WFIRM)
Bioartificial Organ Manufacturing Segment by Type
Semi-automatic
Fully Automatic
Manual
Bioartificial Organ Manufacturing Segment by Application
Hospitals
Research Institutes
Laboratory
Others
Bioartificial Organ Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioartificial Organ Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioartificial Organ Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioartificial Organ Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioartificial Organ Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Semi-automatic
- Fully Automatic
- Manual
Applications
- Hospitals
- Research Institutes
- Laboratory
- Others
Companies covered
- B. Braun
- Boston Scientific Corporation
- ABIOMED
- Asahi Kasei Corporation
- Berlin Heart
- CARMAT
- Jarvik Heart
- SynCardia Systems
- Nipro Europe Group Companies
- Organovo Holdings
- NexImmune
- Diabeloop
- Admetsys
- Defymed
- Pancreum
- Beta Bionics
- Integra LifeSciences
- Wake Forest Institute for Regenerative Medicine (WFIRM)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioartificial Organ Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Semi-automatic
- 2.2.3 Fully Automatic
- 2.2.4 Manual
- 2.3 Bioartificial Organ Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Research Institutes
- 2.3.4 Laboratory
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Bioartificial Organ Manufacturing Breakdown Data by Type
- 3.1 Global Bioartificial Organ Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Bioartificial Organ Manufacturing Forecasted Market Size by Type (2027-2032)
4 Bioartificial Organ Manufacturing Breakdown Data by Application
- 4.1 Global Bioartificial Organ Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Bioartificial Organ Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioartificial Organ Manufacturing Market Perspective (2021-2032)
- 5.2 Global Bioartificial Organ Manufacturing Growth Trends by Region
- 5.2.1 Global Bioartificial Organ Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioartificial Organ Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Bioartificial Organ Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Bioartificial Organ Manufacturing Market Dynamics
- 5.3.1 Bioartificial Organ Manufacturing Industry Trends
- 5.3.2 Bioartificial Organ Manufacturing Market Drivers
- 5.3.3 Bioartificial Organ Manufacturing Market Challenges
- 5.3.4 Bioartificial Organ Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioartificial Organ Manufacturing Players by Revenue
- 6.1.1 Global Top Bioartificial Organ Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Bioartificial Organ Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioartificial Organ Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioartificial Organ Manufacturing Head Office and Area Served
- 6.4 Global Bioartificial Organ Manufacturing Players, Product Type & Application
- 6.5 Global Bioartificial Organ Manufacturing Manufacturers Established Date
- 6.6 Global Bioartificial Organ Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioartificial Organ Manufacturing Market Size (2021-2032)
- 7.2 North America Bioartificial Organ Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioartificial Organ Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Bioartificial Organ Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioartificial Organ Manufacturing Market Size (2021-2032)
- 8.2 Europe Bioartificial Organ Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioartificial Organ Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Bioartificial Organ Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioartificial Organ Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Bioartificial Organ Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioartificial Organ Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioartificial Organ Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioartificial Organ Manufacturing Market Size (2021-2032)
- 10.2 South America Bioartificial Organ Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioartificial Organ Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Bioartificial Organ Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioartificial Organ Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Bioartificial Organ Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioartificial Organ Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioartificial Organ Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 B. Braun
- 12.1.1 B. Braun Company Information
- 12.1.2 B. Braun Business Overview
- 12.1.3 B. Braun Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.1.4 B. Braun Bioartificial Organ Manufacturing Product Portfolio
- 12.1.5 B. Braun Recent Developments
- 12.2 Boston Scientific Corporation
- 12.2.1 Boston Scientific Corporation Company Information
- 12.2.2 Boston Scientific Corporation Business Overview
- 12.2.3 Boston Scientific Corporation Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.2.4 Boston Scientific Corporation Bioartificial Organ Manufacturing Product Portfolio
- 12.2.5 Boston Scientific Corporation Recent Developments
- 12.3 ABIOMED
- 12.3.1 ABIOMED Company Information
- 12.3.2 ABIOMED Business Overview
- 12.3.3 ABIOMED Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.3.4 ABIOMED Bioartificial Organ Manufacturing Product Portfolio
- 12.3.5 ABIOMED Recent Developments
- 12.4 Asahi Kasei Corporation
- 12.4.1 Asahi Kasei Corporation Company Information
- 12.4.2 Asahi Kasei Corporation Business Overview
- 12.4.3 Asahi Kasei Corporation Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.4.4 Asahi Kasei Corporation Bioartificial Organ Manufacturing Product Portfolio
- 12.4.5 Asahi Kasei Corporation Recent Developments
- 12.5 Berlin Heart
- 12.5.1 Berlin Heart Company Information
- 12.5.2 Berlin Heart Business Overview
- 12.5.3 Berlin Heart Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.5.4 Berlin Heart Bioartificial Organ Manufacturing Product Portfolio
- 12.5.5 Berlin Heart Recent Developments
- 12.6 CARMAT
- 12.6.1 CARMAT Company Information
- 12.6.2 CARMAT Business Overview
- 12.6.3 CARMAT Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.6.4 CARMAT Bioartificial Organ Manufacturing Product Portfolio
- 12.6.5 CARMAT Recent Developments
- 12.7 Jarvik Heart
- 12.7.1 Jarvik Heart Company Information
- 12.7.2 Jarvik Heart Business Overview
- 12.7.3 Jarvik Heart Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.7.4 Jarvik Heart Bioartificial Organ Manufacturing Product Portfolio
- 12.7.5 Jarvik Heart Recent Developments
- 12.8 SynCardia Systems
- 12.8.1 SynCardia Systems Company Information
- 12.8.2 SynCardia Systems Business Overview
- 12.8.3 SynCardia Systems Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.8.4 SynCardia Systems Bioartificial Organ Manufacturing Product Portfolio
- 12.8.5 SynCardia Systems Recent Developments
- 12.9 Nipro Europe Group Companies
- 12.9.1 Nipro Europe Group Companies Company Information
- 12.9.2 Nipro Europe Group Companies Business Overview
- 12.9.3 Nipro Europe Group Companies Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.9.4 Nipro Europe Group Companies Bioartificial Organ Manufacturing Product Portfolio
- 12.9.5 Nipro Europe Group Companies Recent Developments
- 12.10 Organovo Holdings
- 12.10.1 Organovo Holdings Company Information
- 12.10.2 Organovo Holdings Business Overview
- 12.10.3 Organovo Holdings Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.10.4 Organovo Holdings Bioartificial Organ Manufacturing Product Portfolio
- 12.10.5 Organovo Holdings Recent Developments
- 12.11 NexImmune
- 12.11.1 NexImmune Company Information
- 12.11.2 NexImmune Business Overview
- 12.11.3 NexImmune Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.11.4 NexImmune Bioartificial Organ Manufacturing Product Portfolio
- 12.11.5 NexImmune Recent Developments
- 12.12 Diabeloop
- 12.12.1 Diabeloop Company Information
- 12.12.2 Diabeloop Business Overview
- 12.12.3 Diabeloop Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.12.4 Diabeloop Bioartificial Organ Manufacturing Product Portfolio
- 12.12.5 Diabeloop Recent Developments
- 12.13 Admetsys
- 12.13.1 Admetsys Company Information
- 12.13.2 Admetsys Business Overview
- 12.13.3 Admetsys Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.13.4 Admetsys Bioartificial Organ Manufacturing Product Portfolio
- 12.13.5 Admetsys Recent Developments
- 12.14 Defymed
- 12.14.1 Defymed Company Information
- 12.14.2 Defymed Business Overview
- 12.14.3 Defymed Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.14.4 Defymed Bioartificial Organ Manufacturing Product Portfolio
- 12.14.5 Defymed Recent Developments
- 12.15 Pancreum
- 12.15.1 Pancreum Company Information
- 12.15.2 Pancreum Business Overview
- 12.15.3 Pancreum Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.15.4 Pancreum Bioartificial Organ Manufacturing Product Portfolio
- 12.15.5 Pancreum Recent Developments
- 12.16 Beta Bionics
- 12.16.1 Beta Bionics Company Information
- 12.16.2 Beta Bionics Business Overview
- 12.16.3 Beta Bionics Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.16.4 Beta Bionics Bioartificial Organ Manufacturing Product Portfolio
- 12.16.5 Beta Bionics Recent Developments
- 12.17 Integra LifeSciences
- 12.17.1 Integra LifeSciences Company Information
- 12.17.2 Integra LifeSciences Business Overview
- 12.17.3 Integra LifeSciences Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.17.4 Integra LifeSciences Bioartificial Organ Manufacturing Product Portfolio
- 12.17.5 Integra LifeSciences Recent Developments
- 12.18 Wake Forest Institute for Regenerative Medicine (WFIRM)
- 12.18.1 Wake Forest Institute for Regenerative Medicine (WFIRM) Company Information
- 12.18.2 Wake Forest Institute for Regenerative Medicine (WFIRM) Business Overview
- 12.18.3 Wake Forest Institute for Regenerative Medicine (WFIRM) Revenue in Bioartificial Organ Manufacturing Business (2021-2026)
- 12.18.4 Wake Forest Institute for Regenerative Medicine (WFIRM) Bioartificial Organ Manufacturing Product Portfolio
- 12.18.5 Wake Forest Institute for Regenerative Medicine (WFIRM) Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst